secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2026-05-11T20:10:17+00:00
Accession:  0001636422-26-000064
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q1 revenue falls 11% YoY; net loss widens to $111M
------------------------------------------------------------------

- Total revenue $70.8M vs $79.4M in Q1 2025; gross margin improved to 39% from 36%.
- Net loss of $111.0M, a 368% increase year-over-year from $23.7M loss in prior-year period.
- CEO Ben Albert says Q1 results exceeded expectations on revenue and adjusted EBITDA.
- Company announces strategic reset to focus on highest-conviction technology opportunities.
- Ticker: HCAT; Nasdaq-listed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000064/0001636422-26-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000064/hcat-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001636422-26-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer